151 related articles for article (PubMed ID: 22967806)
1. Whole-body distribution and radiation dosimetry of 11C-(+)-PHNO, a D2/3 agonist ligand.
Mizrahi R; Rusjan P; Vitcu I; Ng A; Wilson AA; Houle S; Bloomfield PM
J Nucl Med; 2012 Nov; 53(11):1802-6. PubMed ID: 22967806
[TBL] [Abstract][Full Text] [Related]
2. Whole-body radiation dosimetry of 11C-carbonyl-URB694: a PET tracer for fatty acid amide hydrolase.
Boileau I; Bloomfield PM; Rusjan P; Mizrahi R; Mufti A; Vitcu I; Kish SJ; Houle S; Wilson AA; Tong J
J Nucl Med; 2014 Dec; 55(12):1993-7. PubMed ID: 25413137
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PET.
Slifstein M; Hwang DR; Martinez D; Ekelund J; Huang Y; Hackett E; Abi-Dargham A; Laruelle M
J Nucl Med; 2006 Feb; 47(2):313-9. PubMed ID: 16455638
[TBL] [Abstract][Full Text] [Related]
4. Side effects profile in humans of (11)C-(+)-PHNO, a dopamine D(2/3) agonist ligand for PET.
Mizrahi R; Houle S; Vitcu I; Ng A; Wilson AA
J Nucl Med; 2010 Mar; 51(3):496-7. PubMed ID: 20150251
[No Abstract] [Full Text] [Related]
5. 1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation.
Virta JR; Tolvanen T; Någren K; Brück A; Roivainen A; Rinne JO
J Nucl Med; 2008 Mar; 49(3):347-53. PubMed ID: 18287260
[TBL] [Abstract][Full Text] [Related]
6. Whole-body distribution and radiation dosimetry of the dopamine transporter radioligand [(11)C]PE2I in healthy volunteers.
Ribeiro MJ; Ricard M; Lièvre MA; Bourgeois S; Emond P; Gervais P; Dollé F; Syrota A
Nucl Med Biol; 2007 May; 34(4):465-70. PubMed ID: 17499737
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution and Radiation Dosimetry of
Garg PK; Lokitz SJ; Nazih R; Garg S
J Nucl Med; 2017 Mar; 58(3):473-478. PubMed ID: 27660145
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and radiation dosimetry of the serotonin 5-HT₆ ligand [¹¹C]GSK215083 determined from human whole-body PET.
Comley RA; Salinas C; Mizrahi R; Vitcu I; Ng A; Hallett W; Keat N; Wilson AA; Rabiner EA; Laruelle M; Houle S
Mol Imaging Biol; 2012 Aug; 14(4):517-21. PubMed ID: 22076076
[TBL] [Abstract][Full Text] [Related]
9. Dosimetry of a D2/D3 dopamine receptor antagonist that can be used with PET or SPECT.
Mozley PD; Stubbs JB; Kim HJ; McElgin W; Chumpradit S; Kung MP; Romaniello G; Kung HF
J Nucl Med; 1995 Jul; 36(7):1322-31. PubMed ID: 7790963
[TBL] [Abstract][Full Text] [Related]
10. Human radiation dose estimation of (11)C-CFT using whole-body PET.
Huang T; Wang H; Tang G; Liang X; Deng H; Yi C; Zhang X
Clin Nucl Med; 2012 Dec; 37(12):1159-62. PubMed ID: 23154473
[TBL] [Abstract][Full Text] [Related]
11. Whole-body distribution and brain tumor imaging with (11)C-4DST: a pilot study.
Toyohara J; Nariai T; Sakata M; Oda K; Ishii K; Kawabe T; Irie T; Saga T; Kubota K; Ishiwata K
J Nucl Med; 2011 Aug; 52(8):1322-8. PubMed ID: 21764794
[TBL] [Abstract][Full Text] [Related]
12. Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.
Beauregard JM; Croteau E; Ahmed N; van Lier JE; Bénard F
J Nucl Med; 2009 Jan; 50(1):100-7. PubMed ID: 19091905
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and radiation dosimetry in humans of [¹¹C]FLB 457, a positron emission tomography ligand for the extrastriatal dopamine D₂ receptor.
Kimura Y; Ito H; Shiraishi T; Fujiwara H; Kodaka F; Takano H; Shimada H; Kanno I; Suhara T
Nucl Med Biol; 2014 Jan; 41(1):102-5. PubMed ID: 24075253
[TBL] [Abstract][Full Text] [Related]
14. Radiation dose estimates in humans for (11)C-acetate whole-body PET.
Seltzer MA; Jahan SA; Sparks R; Stout DB; Satyamurthy N; Dahlbom M; Phelps ME; Barrio JR
J Nucl Med; 2004 Jul; 45(7):1233-6. PubMed ID: 15235071
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
McCormick PN; Kapur S; Seeman P; Wilson AA
Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
[TBL] [Abstract][Full Text] [Related]
16. Automated preparation of the dopamine D2/3 receptor agonist ligand [11C]-(+)-PHNO for human PET imaging studies.
Plisson C; Huiban M; Pampols-Maso S; Singleton G; Hill SP; Passchier J
Appl Radiat Isot; 2012 Feb; 70(2):380-7. PubMed ID: 22055845
[TBL] [Abstract][Full Text] [Related]
17. Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist.
Searle G; Beaver JD; Comley RA; Bani M; Tziortzi A; Slifstein M; Mugnaini M; Griffante C; Wilson AA; Merlo-Pich E; Houle S; Gunn R; Rabiner EA; Laruelle M
Biol Psychiatry; 2010 Aug; 68(4):392-9. PubMed ID: 20599188
[TBL] [Abstract][Full Text] [Related]
18. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
Varrone A; Stepanov V; Nakao R; Tóth M; Gulyás B; Emond P; Deloye JB; Vercouillie J; Stabin MG; Jonsson C; Guilloteau D; Halldin C
J Nucl Med; 2011 Aug; 52(8):1313-21. PubMed ID: 21764797
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution and Radiation Dosimetry for the Tau Tracer
Hsiao IT; Lin KJ; Huang KL; Huang CC; Chen HS; Wey SP; Yen TC; Okamura N; Hsu JL
J Nucl Med; 2017 Sep; 58(9):1498-1503. PubMed ID: 28336780
[No Abstract] [Full Text] [Related]
20. Internal dose assessment of (-)-18F-flubatine, comparing animal model datasets of mice and piglets with first-in-human results.
Sattler B; Kranz M; Starke A; Wilke S; Donat CK; Deuther-Conrad W; Patt M; Schildan A; Patt J; Smits R; Hoepping A; Schoenknecht P; Steinbach J; Brust P; Sabri O
J Nucl Med; 2014 Nov; 55(11):1885-92. PubMed ID: 25286922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
